MedCap AB (publ)
Research MedCap AB (publ) (MCAP) on Bullrun: valuation model: 8.6% overvalued, market cap SEK 8.48B, P/E 35.3. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerMCAP
- ExchangeST
- CountrySweden
- SectorHealthcare
- IndustryMedical Devices
- CurrencySEK
- Valuation signal8.6% overvalued
- Market capSEK 8.48B
- P/E35.3
- Financial periodQ2 2026
- RevenueSEK 606.30M
- Net incomeSEK 69.10M
- Free cash flowSEK 107.70M
- Gross margin59.8%
Valuation Snapshot
Bullrun's latest valuation model marks MedCap AB (publ) as 8.6% overvalued; latest market cap is SEK 8.48B; P/E is 35.3.
Peer valuation comparison
Latest P/E is 35.26x versus a Healthcare sector median of 24.46x (44.2% above).
Latest P/E is 35.26x versus a Sweden median of 18.57x (89.9% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | SEK 2.12B | SEK 219.90M | n/a | 58.6% | n/a | SEK 370.40M | SEK 482.90M | SEK 1.45B |
| FY2024 | SEK 1.83B | SEK 207.30M | n/a | 58.6% | n/a | SEK 370.10M | SEK 358.00M | SEK 1.28B |
| FY2023 | SEK 1.61B | SEK 172.10M | n/a | 58.4% | n/a | SEK 188.20M | n/a | n/a |
| FY2022 | SEK 1.15B | SEK 117.50M | n/a | 61.3% | n/a | SEK 236.20M | n/a | n/a |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-23 | SEK 8.48B | 35.3 | n/a | n/a |
About MedCap AB (publ)
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. It prefers to invest in Biotechnology; Life sciences; Pharmaceuticals; MedTech including healthcare equipment, software, components, and packaging solutions for life science products;
Related stock research
Other Healthcare stocks
Frequently asked questions
Is MedCap AB (publ) overvalued or undervalued?
Bullrun's valuation model currently marks MedCap AB (publ) as 8.6% overvalued.
What is MedCap AB (publ)'s market cap?
MedCap AB (publ)'s market capitalization is SEK 8.48B.
What is MedCap AB (publ)'s P/E ratio?
MedCap AB (publ)'s price-to-earnings (P/E) ratio is 35.3.
What does MedCap AB (publ) do?
MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. It prefers to invest in Biotechnology; Life sciences; Pharmaceuticals; MedTech including healthcare equipment, software, components, and packaging solutions for life science products; and Assistive Tech including digital and physical solutions in cognition, communication, environmental control, alarms, mobility, accessibility, and orthotics.